DIAGNOSTIC ACCURACY OF DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING IN DETECTING DEEP MYOMETRIAL INVASION BY ENDOMETRIAL TUMOR TAKING HISTOPATHOLOGY AS GOLD STANDARD
DOI:
https://doi.org/10.70520/kjms.v18i3.713Keywords:
Diffusion-weighted MRI, endometrial cancer, myometrial invasion, histopathology, diagnostic accuracy, gynecologic oncologyAbstract
Objective: To evaluate the diagnostic accuracy of DW-MRI in detecting deep myometrial invasion in endometrial carcinoma, using histopathology as the reference standard.
Methods: This cross-sectional validation study was conducted at the Department of Radiology, Hayatabad Medical Complex, Peshawar, from January to June 2023. A total of 124 women (aged 30–70 years) with biopsy-proven endometrial carcinoma scheduled for hysterectomy were enrolled. DW-MRI findings were interpreted by an experienced radiologist and compared with postoperative histopathological results. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall diagnostic accuracy were calculated.
Results: DW-MRI demonstrated a sensitivity of 81.5% (95% CI: 72.1–88.9%) and a specificity of 87.5% (95% CI: 71.0–96.5%) in detecting deep myometrial invasion. The positive predictive value was 94.9%, and the negative predictive value was 62.2%, with an overall diagnostic accuracy of 83.1%. Performance was superior in postmenopausal women and low-grade tumors.
Conclusion: DW-MRI exhibits high diagnostic accuracy in assessing deep myometrial invasion in endometrial carcinoma, supporting its role as a reliable preoperative imaging modality. Its non-invasive nature and high reproducibility make it a valuable tool in clinical practice.
References
1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.
2. Dane C, Bakir S. The effect of myometrial invasion on prognostic factors and survival analysis in endometrial carcinoma. Afr Health Sci. 2019;19(4):3235-41.
3. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, et al. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet. 2023;162(2):383-94.
4. Beddy P, Moyle P, Kataoka M, Yamamoto AK, Joubert I, Lomas D, et al. Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology. 2012;262(2):530-7.
5. Tian S, Liu A, Zhu W, Li Y, Chen L, Chen A, et al. Difference in Diffusion-Weighted Magnetic Resonance Imaging and Diffusion Tensor Imaging Parameters Between Endometrioid Endometrial Adenocarcinoma and Uterine Serous Adenocarcinoma: A Retrospective Study. Int J Gynecol Cancer. 2017;27(8):1708-13.
6. Guo Y, Wang P, Wang P, Gao W, Li F, Yang X, et al. Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging. Onco Targets Ther. 2017;10:5937-43.
7. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188(6):1622-35.
8. Yu Q, Reutens D, O'Brien K, Vegh V. Tissue microstructure features derived from anomalous diffusion measurements in magnetic resonance imaging. Hum Brain Mapp. 2017;38(2):1068-81.
9. Tanaka T, Terai Y, Fujiwara S, Tanaka Y, Sasaki H, Tsunetoh S, et al. Preoperative diffusion-weighted magnetic resonance imaging and intraoperative frozen sections for predicting the tumor grade in endometrioid endometrial cancer. Oncotarget. 2018;9(93):36575-84.
10. Jónsdóttir B, Ripoll MA, Bergman A, Silins I, Poromaa IS, Ahlström H, et al. Validation of (18)F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study. Cancer Imaging. 2021;21(1):34.
11. Moestue SA, Huuse EM, Lindholm EM, Bofin A, Engebraaten O, Mælandsmo GM, et al. Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts. J Magn Reson Imaging. 2013;38(5):1043-53.
12. Masroor I, Afzal S, Pathan H. Accuracy of Diffusion Weighted Imaging in Assessment of Pelvic Lymphnode Metastasis in Patients with Endometrial Cancer. J Coll Physicians Surg Pak. 2023;33(7):738-41.
13. Wong M, Amin T, Thanatsis N, Naftalin J, Jurkovic D. A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer. J Gynecol Oncol. 2022;33(2):e22.
14. Petrila O, Stefan AE, Gafitanu D, Scripcariu V, Nistor I. The Applicability of Artificial Intelligence in Predicting the Depth of Myometrial Invasion on MRI Studies-A Systematic Review. Diagnostics (Basel). 2023;13(15).
15. Gagliardi T, Adejolu M, deSouza NM. Diffusion-Weighted Magnetic Resonance Imaging in Ovarian Cancer: Exploiting Strengths and Understanding Limitations. J Clin Med. 2022;11(6).
16. Nougaret S, Horta M, Sala E, Lakhman Y, Thomassin-Naggara I, Kido A, et al. Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology. Eur Radiol. 2019;29(2):792-805.
17. Zhang J, Yu X, Zhang X, Chen S, Song Y, Xie L, et al. Whole-lesion apparent diffusion coefficient (ADC) histogram as a quantitative biomarker to preoperatively differentiate stage IA endometrial carcinoma from benign endometrial lesions. BMC Medical Imaging. 2022;22(1):139.
18. Meng X, Yang D, Deng Y, Xu H, Jin H, Yang Z. Diagnostic accuracy of MRI for assessing lymphovascular space invasion in endometrial carcinoma: a meta-analysis. Acta Radiologica. 2024;65(1):133-44.
19. Wang L-J, Tseng Y-J, Wee NK, Low JJH, Tan CH. Diffusion-weighted imaging versus dynamic contrast-enhanced imaging for pre-operative diagnosis of deep myometrial invasion in endometrial cancer: A meta-analysis. Clinical Imaging. 2021;80:36-42.
